XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Treasury Stock
Noncontrolling Interests in Subsidiaries
Total
Balance at Dec. 27, 2020 $ 453 $ 254,103 $ (14,168) $ 219,158 $ (741,724) $ 15,239 $ (266,939)
Balance (in shares) at Dec. 27, 2020 32,545            
Net income       33,883   613 34,496
Other comprehensive income, net of tax     2,197       2,197
Cash dividends on common stock   31   (7,435)     (7,404)
Cash dividends on preferred stock       (3,412)     (3,412)
Exercise of stock options   2,298         2,298
Exercise of stock options (in shares) 41            
Acquisition of Company common stock         (1,267)   (1,267)
Acquisition of Company common stock (in shares) (15)            
Stock-based compensation expense   4,113         4,113
Issuance of restricted stock   (5,371)     5,371    
Issuance of restricted stock (in shares) 104            
Tax effect of restricted stock awards   (3,834)         (3,834)
Distributions to noncontrolling interests           (570) (570)
Other   (55)   (75) 352   222
Other (in shares) 6            
Balance at Mar. 28, 2021 $ 453 251,285 (11,971) 242,119 (737,268) 15,282 (240,100)
Balance (in shares) at Mar. 28, 2021 32,681            
Balance at Dec. 26, 2021 $ 490 445,126 (9,971) 183,157 (806,472) 15,212 (172,458)
Balance (in shares) at Dec. 26, 2021 35,797            
Net income       10,494   423 10,917
Other comprehensive income, net of tax     655       655
Cash dividends on common stock   47   (12,655)     (12,608)
Exercise of stock options   741         741
Exercise of stock options (in shares) 17            
Tax payments for equity award issuances   (7,461)         (7,461)
Tax payments for equity award issuances (in shares) (69)            
Acquisition of Company common stock         (32,709)   (32,709)
Acquisition of Company common stock (in shares) (301)            
Stock-based compensation expense $ 1 4,175         4,176
Issuance of restricted stock   (6,369)     6,369    
Issuance of restricted stock (in shares) 228            
Other   (34)   128 209   303
Other (in shares) 3            
Balance at Mar. 27, 2022 $ 491 $ 436,225 $ (9,316) $ 181,124 $ (832,603) $ 15,635 $ (208,444)
Balance (in shares) at Mar. 27, 2022 35,675